LAVAL, Quebec, Aug. 30, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") today announced that Joseph C. Papa, Chairman and CEO, will participate in the following healthcare conferences in September:
- Wells Fargo Healthcare Conference on Wednesday, September 7, at 3:30 p.m. ET at the Westin Waterfront Hotel in Boston; and,
- Morgan Stanley Global Healthcare Conference on Tuesday, September 13, at 9:10 a.m. ET at the Grand Hyatt Hotel in New York City.
A live webcast and audio archive of the events will be available on Valeant's Investor Relations website and via this URL: http://ir.valeant.com/events-and-presentations/2016.
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
877-281-6642 (toll free)
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-to-participate-in-september-healthcare-conferences-300320360.html
SOURCE Valeant Pharmaceuticals International, Inc.